The Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine hosted its third annual symposium on September 17, 2022, under the leadership of Dr. Hashem El-Serag. The event featured a keynote address by Dr. John Ward, director of the Task Force for Global Health’s Coalition for Global Hepatitis Elimination, who discussed how to move from science to policy to eliminate hepatocellular carcinoma (HCC), the most common type of primary liver cancer.
This year's symposium combined presentations on current HCC research with a multi-stakeholder conference that brought together elected officials and decision-makers, community groups and industry representatives. Veterans Affairs leadership and professional societies also convened to discuss HCC in Texas and how they might guide strategies to improve HCC prevention, screening, diagnosis and treatment.
With one of the highest rates of end-stage liver disease and liver cancer in the country, Texas is uniquely impacted by this issue. Stakeholders across the care continuum considered how best to bridge the gaps in prevention and treatment of HCC in Texas, with a focus on driving advocacy efforts for policies aimed at statewide elimination of liver cancer/HCC and hepatitis.
This event was co-sponsored by the Baker Institute Center for Health and Biosciences and the Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine (funded by the Cancer Prevention and Research Institute of Texas).
Follow @BakerCHB on Twitter, and join the conversation online with #BakerHealth.
To View the entire conference, please click below:
Registration
Registration has closed.
Events and webinars are powered by the contributions of our donors and members. Please consider supporting our work by making a gift or joining a membership group. Learn more here or text BAKER to 243725 to give today.
Agenda
8:00 am |
Session I: Overview of the Liver Cancer Epidemic in TexasModerator: Amit Singal, M.D., Medical Director, Liver Tumor Program and Clinical Chief of Hepatology, UT Southwestern Medical Center Welcome and Overview
|
8:40 am |
Session II: Advances and Gaps in Risk Assessment and PreventionModerator: Jane Montealegre, Ph.D., Deputy Director, Office of Outreach and Health Disparities, Dan L. Duncan Comprehensive Cancer Center; Assistant Professor, Department of Pediatrics, Baylor College of Medicine Current State of Prevention in Liver Cancer and Gaps in Prevention
|
9:40 am |
Discussion |
10:00 am |
Coffee Break |
10:20 am |
Session III: Advances and Gaps in Detection and TreatmentModerator: Sumeet Asrani, M.D., MSc, Transplant Hepatologist, Baylor University Medical Center, Baylor Scott & White Health Current State of the Science in Detection and Diagnosis of Liver Cancer
|
11:20 am |
Discussion |
11:40 am |
Keynote Address and LunchJohn Ward, M.D. |
12:20 pm |
Session IV: Implementing ChangeModerator: Hashem El-Serag, M.D., MPH, Chair and Professor, Department of Medicine, Baylor College of Medicine Toward Policy Change — Payer Perspective
|
1:00 pm |
Multi-stakeholder Meeting |
2:30 pm |
Adjourn |